CervoMed Inc. ( CRVO) - Key Metrics
CRVO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.64 | -$0.68 | -$0.68 |
| 2026Q1 | $0 | -$0.86 | -$0.87 | -$0.87 |
| 2025Q4 | $0 | -$0.87 | -$0.71 | -$0.71 |
| 2025Q3 | $0.03 | -$0.84 | -$0.70 | -$0.70 |
| 2025Q2 | $0 | -$0.70 | -$0.73 | -$0.73 |
CRVO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.21 |
| 2026Q1 | 0% | -1.15 |
| 2025Q4 | 0% | -2.27 |
| 2025Q3 | 0% | -2.41 |
| 2025Q2 | 0% | -2.25 |
CRVO
Price: $2.62
52 week price:
Earnings Per Share: -3.01 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 38.7 million